MA26693A1 - COMPOSITIONS FOR ORAL ADMINISTRATION - Google Patents

COMPOSITIONS FOR ORAL ADMINISTRATION

Info

Publication number
MA26693A1
MA26693A1 MA25782A MA25782A MA26693A1 MA 26693 A1 MA26693 A1 MA 26693A1 MA 25782 A MA25782 A MA 25782A MA 25782 A MA25782 A MA 25782A MA 26693 A1 MA26693 A1 MA 26693A1
Authority
MA
Morocco
Prior art keywords
compositions
oral administration
oral
administration
Prior art date
Application number
MA25782A
Other languages
French (fr)
Inventor
Bruce Balik Samuel
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26693A1 publication Critical patent/MA26693A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA25782A 1998-09-28 1999-09-23 COMPOSITIONS FOR ORAL ADMINISTRATION MA26693A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10211298P 1998-09-28 1998-09-28

Publications (1)

Publication Number Publication Date
MA26693A1 true MA26693A1 (en) 2004-12-20

Family

ID=22288187

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25782A MA26693A1 (en) 1998-09-28 1999-09-23 COMPOSITIONS FOR ORAL ADMINISTRATION

Country Status (17)

Country Link
EP (1) EP1117407A1 (en)
JP (1) JP2002525328A (en)
KR (1) KR20010075385A (en)
CN (1) CN1328459A (en)
AR (1) AR022673A1 (en)
AU (1) AU6087399A (en)
BR (1) BR9914096A (en)
CA (1) CA2345638A1 (en)
CZ (1) CZ20011142A3 (en)
HU (1) HUP0103459A2 (en)
IL (1) IL142054A0 (en)
MA (1) MA26693A1 (en)
NO (1) NO20011555D0 (en)
PE (1) PE20001087A1 (en)
PL (1) PL346877A1 (en)
TR (1) TR200100863T2 (en)
WO (1) WO2000018406A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7750100A (en) * 1999-10-13 2001-04-23 Glaxo Group Limited Method for the treatment of obesity
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use

Also Published As

Publication number Publication date
NO20011555L (en) 2001-03-27
TR200100863T2 (en) 2001-07-23
KR20010075385A (en) 2001-08-09
CN1328459A (en) 2001-12-26
NO20011555D0 (en) 2001-03-27
IL142054A0 (en) 2002-03-10
CZ20011142A3 (en) 2001-09-12
PL346877A1 (en) 2002-03-11
WO2000018406A1 (en) 2000-04-06
JP2002525328A (en) 2002-08-13
AR022673A1 (en) 2002-09-04
BR9914096A (en) 2001-07-31
PE20001087A1 (en) 2000-10-20
HUP0103459A2 (en) 2002-01-28
EP1117407A1 (en) 2001-07-25
AU6087399A (en) 2000-04-17
CA2345638A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
FR08C0004I2 (en) One dose oral composition for sustained release
NO20020208D0 (en) Liquid compositions for oral administration
MA26621A1 (en) COMPOSITION FOR PHARMACEUTICAL AEROSOLS
EA199900373A3 (en) PHARMACEUTICAL COMPOSITIONS
FR2775596B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
PT1242087E (en) PHARMACEUTICAL COMPOSITIONS
DK1140109T3 (en) Three-phase oral contraceptive
ID27415A (en) PHARMACEUTICAL COMPOSITION
NO20015175L (en) Pharmaceutical composition
ID26720A (en) ORAL COMPOSITION
ITMI982222A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENERPHINE
DE69822172D1 (en) LEVOSIMENT-CONTAINING ORAL MEDICINAL COMPOSITIONS
ID27201A (en) PHARMACEUTICAL COMPOSITION
NO20020760L (en) Pharmaceutical compositions for oral and topical administration
PT1239832E (en) PHARMACEUTICAL COMPOSITIONS
NO996044L (en) Rapamycin formulations for oral administration
PT102384A (en) PHARMACEUTICAL COMPOSITIONS COMPOSING PAROXENTINE METHANOSULPHONATE
FR2779145B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
EE200100281A (en) Analgesic pharmaceutical composition
FR2751534B1 (en) COMPOSITION FOR IMPROVING ORAL HYGIENE
MA26693A1 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
IL149422A0 (en) Oral pharmaceutical compositions for liver therapy
EE200000459A (en) Pharmaceutical compositions
FI981567A0 (en) Pharmaceutical compositions
SE9800052D0 (en) Pharmaceutical compositions